China Biotech IPOs Remain In Deep Freeze, Hong Kong Fares Better

 
• By Dexter Jie Yan
IPO
China freeze on biopharma IPOs continues, although Hong Kong sees several floats • Source: Shutterstock

More from China

More from Focus On Asia